Doctors and researchers gathered at a recent American Urological Association (AUA) meeting to discuss the risks of transvaginal mesh. The AUA has reconsidered its stance on the use of transvaginal mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI) due to the number of women complaining of severe complications after surgery.
Doctor Jerry Blaivas says that he has personally dealt with many patients who come to him to fix serious complications, including organ injury, erosion, exposure, bladder and urethral erosion, painful intercourse and pelvic pain. Several companies have issued transvaginal mesh recalls after women have come forward with complications.
Transvaginal mesh lawsuits allege that manufacturers such as Johnson & Johnson, C.R. Bard and Boston Scientific developed defective devices which led to serious injuries. Manufacturer Endo recently settled nearly 20,000 mesh injury lawsuits for $830 million.